Literature DB >> 10627481

Alternative splicing of protein 4.1R exon 16: ordered excision of flanking introns ensures proper splice site choice.

S L Gee1, K Aoyagi, R Lersch, V Hou, M Wu, J G Conboy.   

Abstract

Alternative splicing plays a major role in regulating tissue-specific expression of cytoskeletal protein 4.1R isoforms. In particular, expression of the protein's functionally critical spectrin-actin binding domain, essential for maintenance of red cell membrane mechanical properties, is governed by a developmentally regulated splicing switch involving alternative exon 16. Using a model 3-exon 4.1R pre-messenger RNA (pre-mRNA), we explored the sequence requirements for excision of the introns flanking exon 16. These studies revealed that splicing of this alternative exon occurs preferentially in an ordered fashion. The first step is excision of the downstream intron to join exons 16 and 17, followed by excision of the upstream intron. Constructs designed to test the converse pathway were spliced less efficiently and with less fidelity, in part due to activation of a cryptic 5' splice site in exon 16. This downstream-first model for ordered splicing is consistent with the hypothesis that regulated alternative splicing requires cooperation between multiple exonic and/or intronic regulatory elements whose spatial organization is critical for recruitment of appropriate splicing factors. Our results predict that exon 16 splicing is regulated at the first step-excision of the downstream intron-and that cells unable to catalyze this step will exhibit exon 16 skipping. In cells that include exon 16, adherence to an ordered pathway is important for efficient and accurate production of mature 4.1R mRNA encoding an intact spectrin-actin binding domain. (Blood. 2000;95:692-699)

Mesh:

Substances:

Year:  2000        PMID: 10627481

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch.

Authors:  Victor C Hou; Robert Lersch; Sherry L Gee; Julie L Ponthier; Annie J Lo; Michael Wu; Chris W Turck; Mark Koury; Adrian R Krainer; Akila Mayeda; John G Conboy
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

2.  Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation.

Authors:  Nathan Salomonis; Christopher R Schlieve; Laura Pereira; Christine Wahlquist; Alexandre Colas; Alexander C Zambon; Karen Vranizan; Matthew J Spindler; Alexander R Pico; Melissa S Cline; Tyson A Clark; Alan Williams; John E Blume; Eva Samal; Mark Mercola; Bradley J Merrill; Bruce R Conklin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

3.  IGF1 mRNA isoform expression in the cervix of HPV-positive women with pre-cancerous and cancer lesions.

Authors:  Maria Magdalena Koczorowska; Anna Kwasniewska; Anna Gozdzicka-Jozefiak
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

Review 4.  RNA splicing during terminal erythropoiesis.

Authors:  John G Conboy
Journal:  Curr Opin Hematol       Date:  2017-05       Impact factor: 3.284

5.  Beta-spectrinBari: a truncated beta-chain responsible for dominant hereditary spherocytosis.

Authors:  Silverio Perrotta; Fulvio Della Ragione; Francesca Rossi; Rosa Anna Avvisati; Daniela Di Pinto; Giovanna De Mieri; Saverio Scianguetta; Silvia Mancusi; Luigia De Falco; Vito Marano; Achille Iolascon
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.